Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
$33.06
+0.1%
$33.28
$21.30
$35.69
$1.58B0.38382,346 shs105,887 shs
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
$68.49
$68.47
$21.65
$73.02
$4.62B0.452.07 million shs74 shs
Summit Materials, Inc. stock logo
SUM
Summit Materials
$52.54
+0.2%
$52.54
$34.80
$54.07
$9.23B1.132.28 million shs4.69 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
+0.61%-0.82%+1.63%+7.92%+54.69%
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
0.00%0.00%0.00%0.00%0.00%
Summit Materials, Inc. stock logo
SUM
Summit Materials
0.00%0.00%0.00%0.00%+45.62%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
4.0842 of 5 stars
0.02.03.34.72.43.31.9
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Summit Materials, Inc. stock logo
SUM
Summit Materials
0.2279 of 5 stars
1.10.00.00.00.00.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
0.00
N/AN/AN/A
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
0.00
N/AN/AN/A
Summit Materials, Inc. stock logo
SUM
Summit Materials
2.17
Hold$51.20-2.55% Downside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
$4.28B0.37$4.10 per share8.06$41.86 per share0.79
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
$194.75M23.73N/AN/A$3.05 per share22.46
Summit Materials, Inc. stock logo
SUM
Summit Materials
$2.62B3.52$3.48 per share15.08$19.38 per share2.71
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
$142.20M$3.0610.80N/A3.45%6.52%4.17%8/7/2025 (Estimated)
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
-$303.09M-$5.01N/AN/AN/A-137.30%-170.37%-39.24%N/A
Summit Materials, Inc. stock logo
SUM
Summit Materials
$289.63M$0.8264.0726.27N/A3.92%6.90%3.52%N/A

Latest DTL, FDP, GFT, SUM, and GBT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/31/2025Q2 2025
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
$0.95N/AN/AN/A$1.16 billionN/A
4/30/2025Q1 2025
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
$0.62$0.63+$0.01$0.64$1.12 billion$1.10 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
$1.203.63%N/A39.22%5 Years
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
N/AN/AN/AN/AN/A
Summit Materials, Inc. stock logo
SUM
Summit Materials
N/AN/AN/AN/AN/A

Latest DTL, FDP, GFT, SUM, and GBT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
quarterly$0.303.3%5/14/20255/14/20256/6/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
0.12
2.05
1.01
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
4.92
6.88
6.17
Summit Materials, Inc. stock logo
SUM
Summit Materials
0.62
3.10
2.48

Institutional Ownership

CompanyInstitutional Ownership
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
64.83%
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
N/A
Summit Materials, Inc. stock logo
SUM
Summit Materials
N/A

Insider Ownership

CompanyInsider Ownership
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
30.10%
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
4.90%
Summit Materials, Inc. stock logo
SUM
Summit Materials
0.55%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fresh Del Monte Produce, Inc. stock logo
FDP
Fresh Del Monte Produce
39,88647.93 million33.50 millionOptionable
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
45767.48 million64.17 millionOptionable
Summit Materials, Inc. stock logo
SUM
Summit Materials
4,800175.60 million174.64 millionOptionable

Recent News About These Companies

Summit Materials
Large M&A Fizzles Worldwide In February
Nigeria to host Africa raw materials summit
Summit Materials (SUM) Receives a Hold from D.A. Davidson
Summit Materials Completes Merger with Quikrete

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Fresh Del Monte Produce stock logo

Fresh Del Monte Produce NYSE:FDP

$33.06 +0.05 (+0.14%)
As of 02:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Fresh Del Monte Produce Inc., through its subsidiaries, produces, markets, and distributes fresh and fresh-cut fruits and vegetables in North America, Central America, South America, Europe, the Middle East, Africa, Asia, and internationally. It operates through three segments: Fresh and Value-Added Products, Banana, and Other Products and Services. The company offers pineapples, fresh-cut fruit, fresh-cut vegetables, melons, and vegetables; non-tropical fruits, such as grapes, apples, citrus, blueberries, strawberries, pears, peaches, plums, nectarines, cherries, and kiwis; other fruit and vegetables, and avocados; and prepared fruit and vegetables, juices, other beverages, and meals and snacks. It also engages in the sale of poultry and meat products; and third-party freight services business. The company offers its products under the Del Monte brand, as well as under other brands, such as UTC, Rosy, Just Juice, Fruitini, Pinkglow, Del Monte Zero, Honeyglow, Rubyglow, Honey Miniglow, Bananinis, Mann, Mann's Logo, Arcadian Harvest, Nourish Bowls, Broccolini, Caulilini, Better Burger Leaf, Romaleaf, and other regional brands. It markets and distributes its products to retail stores, club stores, convenience stores, wholesalers, distributors, and foodservice operators. Fresh Del Monte Produce Inc. was founded in 1886 and is based in George Town, Cayman Islands.

Global Blood Therapeutics stock logo

Global Blood Therapeutics NASDAQ:GBT

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.

Summit Materials stock logo

Summit Materials NYSE:SUM

$52.54 +0.09 (+0.17%)
Closing price 02/10/2025
Extended Trading
$52.54 0.00 (0.00%)
As of 02/10/2025 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Summit Materials, Inc. is a vertically integrated construction materials company, which engages in manufacturing construction materials and related downstream products. It operates through the following segments: West, East, and Cement. The West segment includes operations in Texas, Utah, Arizona, Colorado, Idaho, Wyoming, Oklahoma, Arkansas and British Columbia, Canada. The East segments refers to its East and Central regions and serves markets extending across the Midwestern and Eastern United States. The Cement segment is involved in Hannibal, Missouri and Davenport, Iowa cement plants, and distribution terminals along the Mississippi River from Minnesota to Louisiana. The company was founded by Thomas W. Hill on September 23, 2014 and is headquartered in Denver, CO.